Literature DB >> 9847332

RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.

C Martinand1, C Montavon, T Salehzada, M Silhol, B Lebleu, C Bisbal.   

Abstract

The interferon-regulated 2-5A/RNase L pathway plays a major role in the antiviral and antiproliferative activities of these cytokines. Several viruses, however, have evolved strategies to escape the antiviral activity of the 2-5A/RNase L pathway. In this context, we have cloned a cDNA coding for the RNase L inhibitor (RLI), a protein that specifically inhibits RNase L and whose regulated expression in picornavirus-infected cells down regulates the activity of the 2-5A/RNase L pathway. We show here that RLI increases during the course of human immunodeficiency virus type 1 (HIV-1) infection, which may be related to the downregulation of RNase L activity that has been described to occur in HIV-infected cells. In order to establish a possible causal relationship between these observations, we have stably transfected H9 cells with RLI sense or antisense cDNA-expressing vectors. The overexpression of RLI causes a decrease in RNase L activity and a twofold enhancement of HIV production. This increase in HIV replication correlates with an increase in HIV RNA and proteins. In contrast, reduction of RLI levels in RLI antisense cDNA-expressing clones reverses the inhibition of RNase L activity associated with HIV multiplication and leads to a threefold decrease in the viral load. This anti-HIV activity correlated with a decrease in HIV RNA and proteins. These findings demonstrate that the level of RLI, via its modulation of RNase L activity, can severely impair HIV replication and suggest the involvement of RLI in the inhibition of the 2-5A/RNase L system observed during HIV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847332      PMCID: PMC103833     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

Authors:  J Chebath; P Benech; M Revel; M Vigneron
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  Diagnostic value of the determination of an interferon-induced enzyme activity: decreased 2',5'-oligoadenylate dependent binding protein activity in AIDS patient lymphocytes.

Authors:  J M Wu; J W Chiao; S Maayan
Journal:  AIDS Res       Date:  1986

3.  A method for isolation of intact, translationally active ribonucleic acid.

Authors:  G Cathala; J F Savouret; B Mendez; B L West; M Karin; J A Martial; J D Baxter
Journal:  DNA       Date:  1983

4.  Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus.

Authors:  T W Nilsen; P A Maroney; C Baglioni
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.

Authors:  E Paez; M Esteban
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

6.  Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.

Authors:  B Bayard; C Bisbal; B Lebleu
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

7.  Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.

Authors:  P J Cayley; J A Davies; K G McCullagh; I M Kerr
Journal:  Eur J Biochem       Date:  1984-08-15

8.  Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex.

Authors:  W A Carter; D R Strayer; I Brodsky; M Lewin; M G Pellegrino; L Einck; H F Henriques; G L Simon; D M Parenti; R G Scheib
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

9.  Alteration of nuclear (2'-5')oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells.

Authors:  H C Schröder; R Wenger; M Rottmann; W E Müller
Journal:  Biol Chem Hoppe Seyler       Date:  1988-09

10.  Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  D Watling; H T Serafinowska; C B Reese; I M Kerr
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  40 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Identification of novel host cell binding partners of Oas1b, the protein conferring resistance to flavivirus-induced disease in mice.

Authors:  S C Courtney; H Di; B M Stockman; H Liu; S V Scherbik; M A Brinton
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.

Authors:  Jianfeng Li; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

Review 4.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

5.  The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction.

Authors:  Pamela C De La Cruz-Rivera; Mohammed Kanchwala; Hanquan Liang; Ashwani Kumar; Lin-Fa Wang; Chao Xing; John W Schoggins
Journal:  J Immunol       Date:  2017-11-27       Impact factor: 5.422

6.  ABCE1 is essential for S phase progression in human cells.

Authors:  Marina Toompuu; Kairi Kärblane; Pille Pata; Erkki Truve; Cecilia Sarmiento
Journal:  Cell Cycle       Date:  2016-03-17       Impact factor: 4.534

7.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  A plant orthologue of RNase L inhibitor (RLI) is induced in plants showing RNA interference.

Authors:  Antonio Sergio Kimus Braz; Jean Finnegan; Peter Waterhouse; Rogério Margis
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

9.  Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle.

Authors:  Nathalie Desloges; Markus Rahaus; Manfred H Wolff
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

10.  Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

Authors:  Daniela Vendrame; Marion Sourisseau; Virginie Perrin; Olivier Schwartz; Fabrizio Mammano
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.